Related content

Physical therapy in Parkinson’s disease: an open long-term rehabilitation trial

By Pellecchia M.   Grasso A.   Biancardi L.   Squillante M.   Bonavita V.   Barone P.  

Journal of Neurology, Vol. 251, Iss. 5, 2004-05 ,pp. : 595-598

Springer Publishing Company

Access to resources Recommend Favorite

Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease

By Cáceres-Redondo María   Carrillo Fátima   Lama María   Huertas-Fernández Ismael   Vargas-González Laura   Carballo Manuel   Mir Pablo  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 561-569

Springer Publishing Company

Access to resources Recommend Favorite

Nachsorge nach tiefer Hirnstimulation bei Patienten mit M. Parkinson: Long-term care after deep brain stimulation of patients with Parkinson’s disease

By Sixel-Döring F.   Ebersbach G.  

Der Nervenarzt, Vol. 81, Iss. 6, 2010-06 ,pp. : 688-695

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

By Happe S.   Tings T.   Koch W.   Welsch J.   Helmschmied K.   Baier P. C.   Meller J.   Wuttke W.   Paulus W.   Tatsch K.   Trenkwalder C.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 589-594

Springer Publishing Company

Access to resources Recommend Favorite

Melatonin in Parkinson's disease

By Medeiros C.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 759-759

Springer Publishing Company

Access to resources Recommend Favorite